Tag - LENZ

LENZ Therapeutics (NASDAQ:LENZ) has completed its merger with Graphite Bio in an all-stock transaction. LENZ is advancing its lead assets, LNZ100 and LNZ101, which are both preservative-free, single-use, once-daily eye...